Results

Total Results: 635 records

Showing results for "rapid response".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
    February 01, 2013 - ES-2 reduced RLS symptoms, increased the percentage of patients with a clinically important response … and etiology of disease, age, obesity, and other characteristics that appear to have an effect on response … rotigotine) reduced RLS symptoms, increased the percentage of patients with a clinically important response … evidence demonstrated that pregabalin increased the percentage of patients with a clinically important response … stakeholders to clarify or supplement the call summaries or to suggest additional research questions in response
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
    January 01, 2009 - period: attrition rate before randomization and reasons (e.g., nonadherence, adverse drug events, no response … If high levels of nonadherence, adverse effects, or lack of response are found, then this reduces applicability
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - • There is limited indirect comparison evidence that the effect on clinically important response may … Most studies used flexible up-titration based on symptom response and adverse effects, with doses ranging … Compared with placebo, the percentage of patients with a favorable treatment response was greater with … studies as the basis for increasing drug doses or altering administration timing if symptom response … Moreover, clinicians and patients should be aware of such a large placebo response.
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
    December 11, 2012 - Ticagrelor is a reversible P2Y12 receptor antagonist that, when compared with clopidogrel, provides a more rapid … Initial pharmacokinetic/pharmacodynamic studies have suggested a reduction in the antiplatelet response … Based on comments received in response to this posting, the following change was made to the KQs: … Additionally, when appropriate, the studies will be evaluated for dose-response association, the presence
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
    August 18, 2011 - helping patients to better adhere to recommended treatment. 4-6 Over the past half century, rapid … and alternatives to the prescribed medication; and lack of access to a provider who will monitor the response … It also considers other optional domains that may be relevant for some scenarios, such as a dose-response
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
    May 01, 2012 - It is a collaborative network of research centers that support the rapid development of new scientific … early events, especially treatment discontinuations, because of problems with tolerability or poor response … Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis: results from
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - subject matter experts referred to a publication outlining perceived shortcomings of the report and a response … The response from the epilepsy organizations highlighted that the report failed to recognize the different … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response … Assessment of the Need to Update Comparative Effectiveness Reviews: Report of an Initial Rapid Program … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - subject matter experts referred to a publication outlining perceived shortcomings of the report and a response … The response from the epilepsy organizations highlighted that the report failed to recognize the different … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response … Assessment of the Need to Update Comparative Effectiveness Reviews: Report of an Initial Rapid Program … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
    March 22, 2016 - Other factors that may be considered in assessing strength of evidence include dose-response relationship
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
    July 01, 2012 - Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
    April 01, 2010 - It is a collaborative network of research centers that support the rapid development of new scientific … plan for depression should be documented If a patient with cancer is treated for depression, then response
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
    January 01, 2013 - Assessment of the Need to Update Comparative Effectiveness Reviews: Report of an Initial Rapid Program
  13. effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - If C1INH is deficient, an acute inflammatory response occurs that leads to swelling, which is the … If C1INH is deficient, C1 proteases set off the complement pathway, causing an acute inflammatory response … Part of the inflammatory response is the release of uncontrolled levels of bradykinin (BK), a potent … The combination of rapid relief of symptoms and self-administration is expected to improve health outcomes … the retina using tests for refraction, color vision, visual field, visual acuity, and pupil-reflex response
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_executive.pdf
    August 01, 2012 - Nitrous oxide has a rapid onset and end of action.
  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide_executive.pdf
    April 01, 2007 - Layout 1 User’s Guide to Registries Evaluating Patient Outcomes: Summary Advancing Excellence in Health Care • www.ahrq.gov Agency for Healthcare Research and Quality The Effective Health Care Program of the Agency for Healthcare Research and Quality (AHRQ) conducts and supports research focused on…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: